Page last updated: 2024-08-22

zalcitabine and Central Nervous System Toxoplasmosis

zalcitabine has been researched along with Central Nervous System Toxoplasmosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Childress, JF; DeMets, DL; Ellenberg, SS; Fleming, TR; Foulkes, M; Mayer, KH; O'Fallon, J; Pollard, RB; Rahal, JJ; Whitley, RJ1

Other Studies

1 other study(ies) available for zalcitabine and Central Nervous System Toxoplasmosis

ArticleYear
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.
    Controlled clinical trials, 1995, Volume: 16, Issue:6

    Topics: Advisory Committees; Anti-Infective Agents; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Confidentiality; Conflict of Interest; Didanosine; Drug Evaluation; Federal Government; HIV Infections; Humans; National Institutes of Health (U.S.); Organizational Objectives; Professional Staff Committees; Pyrimethamine; Reverse Transcriptase Inhibitors; Risk Assessment; Toxoplasmosis, Cerebral; Treatment Outcome; United States; Zalcitabine; Zidovudine

1995